Skip to main content
Premium Trial:

Request an Annual Quote

NCI Awards BioNanomatrix, Princeton $200K STTR to Develop Nanofluidic Sample-Sorting System

NEW YORK (GenomeWeb News) - BioNanomatrix and Princeton University will use a $200,000 grant from the National Cancer Institute to develop a nanofluidics technology for cell fractionation, the company said today.
 
Under the two-year Small Technology Transfer Research grant, BioNanomatrix and Princeton’s Institute for the Science and Technology of Materials will develop a front-end sample-sorting component for the company’s BioNanomatrix whole-genome analytic platform.  
 
The researchers intend to develop systems that can separate out and sort whole chromosomes from one cell or from multiple cells. The company expects the new system to enable sorting of sub-cellular components by size, which will enable a number of analytic applications, including sequencing, mapping, and epigenetics, “in a real-time, dynamic, bench-top format.”
 
BioNanomatrix, based in Philadelphia, is a Princeton spin-out, and has exclusively licensed its technology from the school.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.